Amlodipine/atorvastatin (Caduet) for preventing heart disease
Wilson, S.A.; Sanford, A.
American Family Physician 73(6): 1067-1068
2006
ISSN/ISBN: 0002-838X PMID: 16570743 Document Number: 601158
Document emailed within 1 workday
Related Documents
Santanu, G.; Suhrita, P.; Mookerjee, S.; Tania, K.; Mita, S.; Pramit, G.; Sharmila, G.; Miraj, M.; Debdutta, M. 2011: Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease Indian Heart Journal 63(5): 434-437Wagner, M.; Goetghebeur, M.; Merikle, E.; Pandya, A.; Chu, P.; Taylor, D.C.A. 2009: Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada Canadian Journal of Clinical Pharmacology 16(2): E331-E345
Bubnova, M.G. 2004: Atorvastatin: lipid lowering activity, pleiotropic properties and efficacy in prevention of atherosclerosis and coronary heart disease Kardiologiia 44(8): 96-104
Walsh, M.N. 2000: In an article last summer, you mentioned that a 0.3 milligram daily dose of estrogen is effective in preventing osteoporosis. Is a dose that low also effective for preventing heart disease? Health News 6(3): 10
Saino, A.; Pomidossi, G.; Perondi, R.; Gregorini, L.; Rimini, A.; Alessio, P.; Zanchetti, A.; Mancia, G. 1994: Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease Journal of Cardiovascular Pharmacology 24(6): 875-882
Kalyuzhin, V.V.; Teplyakov, A.T.; Pushnikova, E.Y.; Bespalova, L.D.; Kalyuzhina, E.V.; Kolesnikov, R.N. 2013: Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome Terapevticheskii Arkhiv 85(5): 68-72
Athyros, V.G.; Mikhailidis, D.P.; Papageorgiou, A.A.; Mercouris, B.R.; Athyrou, V.V.; Symeonidis, A.N.; Basayannis, E.O.; Demitriadis, D.S.; Kontopoulos, A.G. 2002: Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study Current medical research and opinion 18(8): 499-502
Deans, W.; Hoskins, R. 1987: Preventing coronary heart disease Professional Nurse 2(10): 328-329
Oganov, R.G.; Gratsianskiĭ, N.A.; Mazur, N.A.; Lazebnik, L.B.; Belousov, I.B.; Sidorenko, B.A.; Ol'binskaia, L.I.; Vertkin, A.L.; Shevchenko, O.P.; Karpov, I.A. 1992: Circadian rhythm in the clinical course of cardiovascular diseases. Clinical experience using Norvasc (amlodipine) in the treatment of patients with ischemic heart disease and arterial hypertension Kardiologiia 32(5): 99-112
Graf, C.; Bjarnason-Wehrens, B.; Rost, R. 2001: Preventing coronary heart disease by physical activity. How much exercise is necessary? MMW Fortschritte der Medizin 143(4): 28-30
Baszczyński, J.; Sordyl, E.; Karpiński, E. 1988: Methods of preventing arteriosclerosis and ischemic heart disease in adolescence Wiadomosci Lekarskie 41(5): 273-277
Gan'shina, T.S.; Kim, G.A.; Gnezdilova, A.V.; Gorbunov, A.A.; Mirzoian, R.S. 2014: Comparative study of the effect of S-amlodipine nicotinate and amlodipine benzylate on the arterial pressure of awake rats Eksperimental'naia i Klinicheskaia Farmakologiia 77(8): 20-22
Mikunis, R.I.; Serkova, V.K.; Monastyrskiĭ, I.I. 1987: Efficacy of preventing ischemic heart disease and arterial hypertension at a factory manufacturing computer equipment Terapevticheskii Arkhiv 59(5): 118-122
Kucharska, J.; Ulicna, O.; Gvozdjakova, A.; Vancova, O.; Waczulikova, I.; Bozek, P.; Bada, V. 2011: Effects of atorvastatin on heart mitochondrial function and coenzyme Q content in the experiment Bratislavske Lekarske Listy 112(11): 603-604
Rosa, E.Maffini.da.; Fedrizzi el Andari, C.; Spagnól, M.Fernando. 2010: Amlodipine and enalapril in coronary disease Arquivos Brasileiros de Cardiologia 94(3): 403; Author Reply 404 427; Author Reply 428
Feldman, R.; Glińska-Serwin, M. 2001: Deep hypotension with transient oliguria and severe heart failure in course of acute intentional poisoning with amlodipine Polskie Archiwum Medycyny Wewnetrznej 105(6): 495-499
Veyrac, Gëlle.; Cellerin, L.; Jolliet, P. 2006: A case of interstitial lung disease with atorvastatin (Tahor) and a review of the literature about these effects observed under statins Therapie 61(1): 57-67
Bespalova, I.D.; Kaliuzhin, V.V.; Riazantseva, N.V.; Mediantsev, I.A.; Osikhov, I.A.; Murashev, B.I. 2013: Pleiotropic effects of atorvastatin and dynamics of quality of life characteristics in patients with hypertensive disease and metabolic syndrome Klinicheskaia Meditsina 91(12): 46-50
Opie, L.H. 1991: Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine Postgraduate Medical Journal 67 Suppl. 5: S2-S8
Tantikosoom, W.; Thinkhamrop, B.; Kiatchusakul, S.; Jarernsiripornkul, N.; Srinakarin, J.; Ojongpian, S. 2005: Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level Journal of the Medical Association of Thailand 88(3): 399-406